東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

The interaction of prenatal solvent ...

Loffredo, Christopher Albert.

Linked to FindBook

Google Book

Amazon

博客來

The interaction of prenatal solvent exposures with genetic polymorphisms in solvent-metabolizing enzymes: Evaluation of risk among infants with congenital heart defects.

Record Type:	Electronic resources : Monograph/item
Title/Author:	The interaction of prenatal solvent exposures with genetic polymorphisms in solvent-metabolizing enzymes: Evaluation of risk among infants with congenital heart defects./
Author:	Loffredo, Christopher Albert.
Description:	187 p.
Notes:	Source: Dissertation Abstracts International, Volume: 58-03, Section: B, page: 1247.
Contained By:	Dissertation Abstracts International58-03B.
Subject:	Health Sciences, Toxicology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=9725382
ISBN:	059134274X

The interaction of prenatal solvent exposures with genetic polymorphisms in solvent-metabolizing enzymes: Evaluation of risk among infants with congenital heart defects.
Loffredo, Christopher Albert.

The interaction of prenatal solvent exposures with genetic polymorphisms in solvent-metabolizing enzymes: Evaluation of risk among infants with congenital heart defects. - 187 p.

Source: Dissertation Abstracts International, Volume: 58-03, Section: B, page: 1247.

Thesis (Ph.D.)--University of Maryland, Baltimore, 1996.

Birth defects are a major public health problem, among which cardiovascular malformations (CVM) carry a disproportionate burden of mortality and disability. Identifying preventable risk factors for CVM is crucial, yet few risk factors are known. One class of environmental agent associated with increased risk of CVM is organic solvents, used widely in industry and in household products. Genetic polymorphisms in solvent-metabolizing enzymes have been recently discovered: some individuals carry null mutations in glutathione-S-tranferase (GST) mu and theta genes, which alter the metabolism of solvents. To test the hypothesis that polymorphisms in GSTmu and GSTtheta modify the risk of CVM among infants whose mothers reported solvent exposures during pregnancy, stored blood spots from Maryland's Newborn Screening Program were obtained for 328 cases and 480 controls of the Baltimore-Washington Infant Study, a population-based study of risk factors. DNA extracted from the dried blood spots was analyzed by polymerase chain reaction coupled with HPLC to detect homozygous null mutations. Logistic regression analysis was used to adjust case-control odds ratios for confounders while stratifying on effect modifiers. Black infants with the genotype mu+/theta+ (both genes present) whose mothers reported paint exposures were at 7.6 times higher risk (95% confidence interval 1.2-47.1) than were unexposed black infants with the same genotype to have pulmonic valve stenosis; the odds ratio was 6.0 (1.0-37.3) after adjustment for alcohol consumption. There was no significant solvent-genotype interaction among white infants with this heart defect. Similar results were observed among black mu+/theta+ infants with atrial septal defect: the odds ratio was 15.2 (3.0-78.2) for any solvent exposure and 22.7 (3.7-140.9) for paint exposures, but whites were not at increased risk. However, white infants were at increased risk of developing aortic valve stenosis and coarctation of the aorta if their mothers reported exposure to "primary" solvents, a more pure form of exposure (odds ratio = 3.2 (95% CI 1.2-8.4)), but the risk was independent of the GST genotype. Although based on heterogeneous exposures and small numbers of exposed subjects, these results suggest that variations in GST genes mediate susceptibility of certain heart defects to the effects of prenatal solvent exposures.

ISBN: 059134274XSubjects--Topical Terms:

1017752
Health Sciences, Toxicology.

The interaction of prenatal solvent exposures with genetic polymorphisms in solvent-metabolizing enzymes: Evaluation of risk among infants with congenital heart defects.
LDR:03433nmm 2200301 4500 001 1863363
005 20041214145725.5
008 130614s1996 eng d
020 $a 059134274X
035 $a (UnM)AAI9725382
035 $a AAI9725382
040 $a UnM $c UnM
100 1 $a Loffredo, Christopher Albert. $3 1950889
245 1 4 $a The interaction of prenatal solvent exposures with genetic polymorphisms in solvent-metabolizing enzymes: Evaluation of risk among infants with congenital heart defects.
300 $a 187 p.
500 $a Source: Dissertation Abstracts International, Volume: 58-03, Section: B, page: 1247.
500 $a Director: Ellen K. Silbergeld.
502 $a Thesis (Ph.D.)--University of Maryland, Baltimore, 1996.
520 $a Birth defects are a major public health problem, among which cardiovascular malformations (CVM) carry a disproportionate burden of mortality and disability. Identifying preventable risk factors for CVM is crucial, yet few risk factors are known. One class of environmental agent associated with increased risk of CVM is organic solvents, used widely in industry and in household products. Genetic polymorphisms in solvent-metabolizing enzymes have been recently discovered: some individuals carry null mutations in glutathione-S-tranferase (GST) mu and theta genes, which alter the metabolism of solvents. To test the hypothesis that polymorphisms in GSTmu and GSTtheta modify the risk of CVM among infants whose mothers reported solvent exposures during pregnancy, stored blood spots from Maryland's Newborn Screening Program were obtained for 328 cases and 480 controls of the Baltimore-Washington Infant Study, a population-based study of risk factors. DNA extracted from the dried blood spots was analyzed by polymerase chain reaction coupled with HPLC to detect homozygous null mutations. Logistic regression analysis was used to adjust case-control odds ratios for confounders while stratifying on effect modifiers. Black infants with the genotype mu+/theta+ (both genes present) whose mothers reported paint exposures were at 7.6 times higher risk (95% confidence interval 1.2-47.1) than were unexposed black infants with the same genotype to have pulmonic valve stenosis; the odds ratio was 6.0 (1.0-37.3) after adjustment for alcohol consumption. There was no significant solvent-genotype interaction among white infants with this heart defect. Similar results were observed among black mu+/theta+ infants with atrial septal defect: the odds ratio was 15.2 (3.0-78.2) for any solvent exposure and 22.7 (3.7-140.9) for paint exposures, but whites were not at increased risk. However, white infants were at increased risk of developing aortic valve stenosis and coarctation of the aorta if their mothers reported exposure to "primary" solvents, a more pure form of exposure (odds ratio = 3.2 (95% CI 1.2-8.4)), but the risk was independent of the GST genotype. Although based on heterogeneous exposures and small numbers of exposed subjects, these results suggest that variations in GST genes mediate susceptibility of certain heart defects to the effects of prenatal solvent exposures.
590 $a School code: 0373.
650 4 $a Health Sciences, Toxicology. $3 1017752
650 4 $a Health Sciences, Human Development. $3 1019218
650 4 $a Biology, Genetics. $3 1017730
650 4 $a Health Sciences, Obstetrics and Gynecology. $3 1020690
690 $a 0383
690 $a 0758
690 $a 0369
690 $a 0380
710 2 0 $a University of Maryland, Baltimore. $3 1029166
773 0 $t Dissertation Abstracts International $g 58-03B.
790 1 0 $a Silbergeld, Ellen K., $e advisor
790 $a 0373
791 $a Ph.D.
792 $a 1996
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=9725382